Pregnancy outcome in women with intrahepatic cholestasis of pregnancy

  title={Pregnancy outcome in women with intrahepatic cholestasis of pregnancy},
  author={Shashi Kant and Sumeet Attri and Sita Thakur and Ajay Kumar Sood},
  journal={International Journal of Research in Medical Sciences},
  • S. KantS. Attri A. Sood
  • Published 26 May 2020
  • Medicine
  • International Journal of Research in Medical Sciences
Background: Intrahepatic cholestasis of pregnancy is a multifactorial condition of pregnancy diagnosed when otherwise unexplained pruritus with abnormal liver function test and neither of which has an alternative cause. The most appropriate gestational age for the delivery of women with ICP is yet to be determined. The present study is designed to determine whether with active intervention, pregnancy with ICP can be carried to a later gestation. Methods: Fifty Women with diagnosed a case of ICP… 

Tables from this paper

Perinatal follow up and neonatal outcomes of pregnancies with obstetric cholestasis

Individual approach, continuous clinical and laboratory monitoring with adequate therapeutic treatment are necessary in patients with obstetric cholestasis.



Obstetric Outcome During an Era of Active Management for Obstetrics Cholestasis

Serum transaminase levels tended to be higher in patients with poor perinatal outcome, such as stillbirth, fetal distress, and meconium-stained amniotic fluid, at the cost of higher LSCS rate.

Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid.

Evidence suggesting improved prognosis with active treatment and the potential of reducing the associated perinatal mortality is suggested and in an uncontrolled series of three patients with cholestasis of pregnancy, ursodeoxycholic acid seemed to provide safe and effective therapy.

Presence of Obstetrics Cholestasis in Mothers Presenting with Pruritus in Pregnancy: In a Low Resource South Asian Setting

Nearly 1/3 of mothers presenting with pruritus in pregnancy in Sri Lanka are affected by ICP which is associated with an increase in a wide range of adverse maternal and fetal outcomes compared to those with prutitus in the absence of ICP.

The mechanical PR interval in fetuses of women with intrahepatic cholestasis of pregnancy.

Fetal outcome in obstetric cholestasis

It is suggested that intensive fetal surveillance, including amniocentesis for meconium, and induction of labour at term or with a mature lecithin/sphyngomyelin ratio, may reduce the stillbirth rate in this ‘high‐risk’ condition.

Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems.

Current achievements and unsolved problems of ICP are reviewed, suggesting that ursodeoxycholic acid is currently the most effective pharmacologic treatment, whereas obstetric management is still debated.


It is proposed that an ethnic predisposition to develop intrahepatic cholestasis of pregnancy is present in Araucanian women and that the high prevalence of the disease in Chile is mainly influenced by ethnic admixture with this South American Indian (ethnic) group.

A prospective study of 18 patients with cholestasis of pregnancy.

Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution.

A retrospective analysis of the prevalence of obstetric cholestasis in the population of the South Birmingham area in the various ethnic subgroups found the prevalence was significantly higher in the Pakistani and Indian subgroups compared to the whites.

Sex hormones and bile acids in intrahepatic cholestasis of pregnancy

The diagnosis of intrahepatic cholestasis of pregnancy can certainly be made during the pruritic episode before delivery, but for research purposes it is indispensable to have a follow-up to document a complete clinical and laboratory improvement after delivery.